Pharmexcil announces business delegation to Zambia, Tanzania & DR Congo from March 24 to April 1: Shardul Nautiyal, Mumbai Wednesday, February 12, 2025, 08:00 Hrs [IST] The Pharma ...

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

Sri Aurobindo Institute of Pharmacy (SAIP), Indore, successfully hosted a National Conference on “Pharma Innovations: Cross-Disciplinary Approaches in Drug Development and Healthcare” on Friday, ...

India’s CDMO market has seen a record growth trajectory due to cost advantages, technological advancements, and strong ...

Vikram Ahuja, Co-founder, ANSR; and CEO, Talent500 highlights AI integration and talent empowerment as key accelerators as he ...

India's logistics and warehousing sector is on a rapid growth trajectory, driven by increasing investments, digital ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...

A Trump adviser has called India's tariffs 'enormously high'. US stocks rose despite Donald Trump’s announcement of 25% ...